...
首页> 外文期刊>Journal of Medicinal Chemistry >Lead Discovery of Dual G-Quadruplex Stabilizers and Poly(ADP-ribose) Polymerases (PARPs) Inhibitors: A New Avenue in Anticancer Treatment
【24h】

Lead Discovery of Dual G-Quadruplex Stabilizers and Poly(ADP-ribose) Polymerases (PARPs) Inhibitors: A New Avenue in Anticancer Treatment

机译:双链型稳定剂和聚(ADP-核糖)聚合酶(PARP)抑制剂的铅发现:抗癌治疗的新途径

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

G-quadruplex stabilizers are an established opportunity in anticancer chemotherapy. To circumvent the antiproliferative effects of G4 ligands, cancer cells recruit PARP enzymes at telomeres. Herein, starting from the structural similarity of a potent G4 ligand previously discovered by our group and a congeneric PARP inhibitor, a library of derivatives was synthesized to discover the first dual G4/PARP ligand. We demonstrate that a properly decorated thieno[3,2-c]quinolin-4(5H)-one stabilizes the G4 fold in vitro and in cells, induces a DNA damage response localized to telomeres, inhibits PARylation in cells, and has an antiproliferative effect in BRCA2 deficient tumor cells.
机译:G-Quadruplex稳定剂是抗癌化疗的既定机会。 为了避免G4配体的抗增殖作用,癌细胞在端粒下募集PARP酶。 在此,从先前由我们的基团和Congeneric PARP抑制剂发现的强度G4配体的结构相似性开始,合成了一种衍生物文库以发现第一双G4 / PARP配体。 我们证明,在体外和细胞中,稳定的Thieno [3,2-C]喹啉-4(5h)稳定G4折叠,诱导局部损伤的DNA损伤,抑制细胞中的氨基化,并具有抗增殖性 BRCA2缺乏肿瘤细胞的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号